TY - JOUR
T1 - Papillary thyroid carcinoma
T2 - Etiology, assessment, and therapy
AU - Ain, K. B.
PY - 1995
Y1 - 1995
N2 - Most papillary carcinomas do not cause death or significant morbidity. Current modes of therapy when appropriately applied, appear effective for 80% to 90% of patients. The clinical challenge is to identify the minority of patients who will suffer greatly from tumors to direct appropriately the best therapeutic efforts. New appreciation of histologic subtypes of papillary carcinoma has provided fresh clues to identify cancers with poor prognosis. We look forward to innovative therapies to deal with currently untreatable disease.
AB - Most papillary carcinomas do not cause death or significant morbidity. Current modes of therapy when appropriately applied, appear effective for 80% to 90% of patients. The clinical challenge is to identify the minority of patients who will suffer greatly from tumors to direct appropriately the best therapeutic efforts. New appreciation of histologic subtypes of papillary carcinoma has provided fresh clues to identify cancers with poor prognosis. We look forward to innovative therapies to deal with currently untreatable disease.
UR - http://www.scopus.com/inward/record.url?scp=0028786456&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028786456&partnerID=8YFLogxK
U2 - 10.1016/s0889-8529(18)30020-3
DO - 10.1016/s0889-8529(18)30020-3
M3 - Review article
C2 - 8608778
AN - SCOPUS:0028786456
SN - 0889-8529
VL - 24
SP - 711
EP - 760
JO - Endocrinology and Metabolism Clinics of North America
JF - Endocrinology and Metabolism Clinics of North America
IS - 4
ER -
